aspen clinic semaglutide GLP-1 Weight Loss Injections ASPEN CLINIC BATON ROUGE -
Description
Osteoarthritis: Aging of matrix and cellsgoing for a remedy
Consult with your healthcare provider for specific guidance
My doctor advised me to continue my weekly injection as scheduled since I wasnt having any GI symptoms
Pipeline (Phase 3 trials completed, FDA decision pending as of April 2026): Survodutide (BI 456906): Dual GLP-1/glucagon agonist from Boehringer Ingelheim
The anesthesia was antagonized with atipamezole (2.5 mg/kg, s.c., Alzane, Syva)
